CNN —GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on Wednesday.
GSK also said it would pay $70 million to settle a related whistleblower lawsuit filed by a Connecticut laboratory.
Pfizer has agreed to settle most of the Zantac cases against it in state court, according to its most recent financial statement, and Sanofi in April announced that it was settling about 4,000 cases.
Boehringer Ingelheim has not announced any major settlements, but is currently facing a trial over the drug in Oakland, California, state court.
A majority of the remaining state court cases are in Delaware, where a judge in June allowed plaintiffs to present crucial expert testimony that Zantac caused cancer.
Persons:
Jennifer Moore, Brent Wisner, Zantac, Boehringer Ingelheim, “, ” Moore, Wisner
Organizations:
CNN, GSK, Pfizer, Sanofi, Boehringer, Food and Drug Administration, Delaware Supreme Court
Locations:
Connecticut, Oakland , California, Delaware, Florida